Kenneweg, Franziska
Hobohm, Lukas
Bang, Claudia
Gupta, Shashi K.
Xiao, Ke
Thum, Sabrina
Ten Cate, Vincent
Rapp, Steffen
Hasenfuß, Gerd
Wild, Philipp
Konstantinides, Stavros
Wachter, Rolf
Lankeit, Mareike
Thum, Thomas
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (01EO1003, 01EO1003)
Bayer
Deutsche Forschungsgemeinschaft (KFO311)
Medizinische Hochschule Hannover (MHH)
Article History
Received: 29 September 2023
Accepted: 21 February 2024
First Online: 24 February 2024
Competing interests
: F. K. reports no disclosures. L. H. reports lecture/ consultant fees from MSD and Actelion, outside the submitted work. C. B. reports no disclosures. S.K.G. has filed and granted patents in the field of non-coding RNAs, outside the submitted work. K. X. reports no disclosures. S. T. reports no disclosures. V.T. C. reports no disclosures. S. R. reports no disclosures. G. H. reports having received consultancy and lecture honoraria from AstraZeneca, Bayer, Impulse Dynamics, Novartis, Pfizer, Servier, Vifor Pharma, all outside the submitted work. P. W. reports grants from Bayer AG, Bayer Healthcare, Bayer Vital, Daiichi-Sankyo, Novartis, Boehringer Ingelheim, Sanofi-Aventis and consulting fees from DiaSorin, AstraZeneca, all outside the submitted work. S. K. reports grants and personal fees from Bayer AG; grants from Boehringer Ingelheim, grants and personal fees from Actelion, grants and personal fees from Daiichi-Sankyo, grants and personal fees from Biocompatibles Group UK, personal fees from Pfizer-Bristol-Myers Squibb, grants and personal fees from MSD, all outside the submitted work. R. W. reports grants from Medtronic, DFG, EU, Bundesministerium für Bildung und Forschung, Deutsches Zentrum fürHerz-/Kreislaufforschung and personal fees from Boehringer Ingelheim, Pfizer, Bayer, CVRx, Medtronic, BMS, Vifor, Novartis, all outside the submitted work. M. L. reports having received consultancy and lecture honoraria from Actelion, Bayer, BRAHMS—Thermo Fisher scientific, Daiichi-Sankyo, MSD, and Pfizer—Bristol-Myers Squibb and research funding from BRAHMS—Thermo Fisher scientific. T. T. filed and licensed patents about noncoding RNAs. TT is founder and shareholder of Cardior Pharmaceuticals GmbH.